AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $232,530 | -20.9% | 11,500 | 0.0% | 0.00% | – |
Q2 2023 | $293,940 | -16.2% | 11,500 | -2.5% | 0.00% | – |
Q1 2023 | $350,932 | -71.3% | 11,800 | -69.9% | 0.00% | -100.0% |
Q3 2021 | $1,224,000 | -17.7% | 39,220 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $1,488,000 | -34.7% | 39,220 | -24.7% | 0.00% | -33.3% |
Q1 2021 | $2,279,000 | -2.5% | 52,105 | +2.2% | 0.00% | 0.0% |
Q4 2020 | $2,338,000 | +60.5% | 50,960 | +16.2% | 0.00% | +50.0% |
Q3 2020 | $1,457,000 | +7.6% | 43,874 | -4.8% | 0.00% | 0.0% |
Q2 2020 | $1,354,000 | +9.1% | 46,074 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,241,000 | -19.0% | 46,074 | +1.3% | 0.00% | 0.0% |
Q4 2019 | $1,533,000 | -10.0% | 45,488 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $1,704,000 | -7.8% | 45,488 | +7.3% | 0.00% | 0.0% |
Q2 2019 | $1,849,000 | +0.1% | 42,388 | -2.1% | 0.00% | 0.0% |
Q1 2019 | $1,848,000 | -12.8% | 43,288 | -8.5% | 0.00% | -25.0% |
Q4 2018 | $2,119,000 | -42.5% | 47,300 | -12.1% | 0.00% | -20.0% |
Q3 2018 | $3,685,000 | – | 53,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |